Mahnoor Mahnoor

Featured in: Favicon

Articles

Assessment of postoperative death and 5 years overall survival in patients in the West with curative gastric adenocarcinoma who undergo the experimental D2 gastrectomy as compared to the patients who undergo conventional D1 gastrectomy; a systematic revie

Jan 13, 2024 | ejso.com | Muhammad Arsalan Bakhtiar |Mahnoor Mahnoor |Muhammad Bajwa |Rabeea Ahmed

Background: D2 gastrectomy for gastric adenocarcinoma is used in Japan with good outcomes related to mortality and morbidity. In contrast, Western European countries employ D1 gastrectomy for gastric adenocarcinoma because trials have shown that D2 gastrectomy is associated with high adverse events.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →